David E. I. Pyott, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), bought 27,900 shares at $37.00 ($1.0M) on 2016-10-13, disclosed to the SEC on 2016-10-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2024-06-26 | $7.2M | — | Filing → |
| BMRN | BUY | 2020-09-01 | $1.0M | — | Filing → |
| AVY | SELL | 2020-02-05 | $1.3M | — | Filing → |